News und Analysen

Shares of Voyager Technologies (NYSE: VOYG) soared roughly 70% this past week after the aerospace company delivered strong second-quarter growth metrics.

Image source: Getty Images.

Voyager's

Medtronic (NYSE: MDT) and Intuitive Surgical (NASDAQ: ISRG), two medical device leaders, haven't performed well this year. While weakness in the broader healthcare sector hasn't helped, they have

Demand for GLP-1 drugs is soaring. Thanks to recent breakthroughs, medicines in this category are expanding their addressable markets and treating conditions such as obstructive sleep apnea (OSA)

Intuitive Surgical (NASDAQ: ISRG) can be hard to own because the stock is prone to deep drawdowns. It is in a drawdown right now, with the stock down roughly 40% from its early 2025 high. Even after

Maggie Yuen, a director at AtriCure, Inc. (NASDAQ:ATRC), reported a sale of 3,500 shares of common stock on August 5, 2026, according to a recent SEC Form 4 filing.

Transaction value based on SEC

Karen Prange, a director of the company, sold 23,325 shares of common stock in AtriCure, Inc. (NASDAQ:ATRC) on August 5, according to an SEC Form 4 filing.

Transaction value based on SEC Form 4

Rocket Lab Corporation (NASDAQ: RKLB) jumped 9.5% on Friday. The S&P 500 and the Nasdaq Composite were up 0.6% and 1.2%, respectively.

Shares of the rocket and satellite manufacturer were lifted by

Choosing between a high-yield pharmaceutical powerhouse and a diversified healthcare leader requires looking at growth and stability. You must decide whether AbbVie (NYSE:ABBV) or Abbott

The past few years have been rough on Pfizer (NYSE: PFE). The company has generally posted subpar financial results due to weakness within its coronavirus franchise, which once helped it become the

Vertex Pharmaceuticals (NASDAQ: VRTX) has dominated the market for cystic fibrosis (CF) medicines since it earned approval for its first drug in this niche in 2012. To this day, most of the

The AI explosion is presenting exciting opportunities for companies that previously may have been considered tier two players in their sectors. Advanced Micro Devices (NASDAQ:AMD) is a huge business

Shares in Viking Therapeutics (NASDAQ: VKTX) declined by 18.6% in July, according to data from S&P Global Market Intelligence. The decline came during a slow month for newsflow in its pipeline, as

Over the past few years, AbbVie (NYSE: ABBV) has faced significant challenges, including the loss of patent exclusivity for its longtime growth driver, Humira, an immunology medicine. The drugmaker

Many investors are looking to capitalize on nascent markets, such as air taxis and robotaxis, hoping that investing in industry leaders will yield superior returns as these markets mature over the

As of 11:50 AM ET, the Dow Jones Industrial Average (DJINDICES:^DJI) is up 0.80% to 54,521, and the S&P 500 (SNPINDEX:^GSPC) has climbed 0.03% to 7,738, putting both in record-high territory. The Na

Shares of Medtronic (NYSE: MDT), one of the world's largest medical device makers, have declined by more than 30% over the past five years. Higher costs, supply chain bottlenecks, quality control

Shares of Advanced Micro Devices (NASDAQ: AMD) fell about 9% in Tuesday's after-hours session after the chipmaker reported its second-quarter results. That was just hours after the stock closed the